- Home
- FIVN vs SANA Comparison
FIVN vs SANA Comparison
Compare FIVN & SANA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FIVN | SANA |
|---|---|---|
| Founded | 2001 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.4B |
| IPO Year | 2014 | 2021 |
Fundamental Metrics
Financial Performance| Metric | FIVN | SANA |
|---|---|---|
| Price | $18.16 | $4.75 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 6 |
| Target Price | ★ $31.53 | $7.83 |
| AVG Volume (30 Days) | 1.9M | ★ 2.6M |
| Earning Date | 02-19-2026 | 03-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.37 | N/A |
| Revenue | ★ $1,127,466,000.00 | N/A |
| Revenue This Year | $12.29 | N/A |
| Revenue Next Year | $9.40 | N/A |
| P/E Ratio | $50.24 | ★ N/A |
| Revenue Growth | ★ 12.48 | N/A |
| 52 Week Low | $16.96 | $1.26 |
| 52 Week High | $49.90 | $6.55 |
Technical Indicators
Market Signals| Indicator | FIVN | SANA |
|---|---|---|
| Relative Strength Index (RSI) | 42.84 | 54.19 |
| Support Level | $16.96 | $4.61 |
| Resistance Level | $19.51 | $5.20 |
| Average True Range (ATR) | 0.89 | 0.32 |
| MACD | 0.01 | 0.03 |
| Stochastic Oscillator | 38.91 | 51.00 |
Price Performance
Historical ComparisonAbout FIVN Five9 Inc.
Five9 offers cloud-native contact center software enabling digital customer service, sales, and marketing engagement. The company's Virtual Contact Center platform combines core telephony functionality, omnichannel engagement, and various modules into a unified cloud contact-center-as-a-service, or CCaaS, platform. Five9's modules include digital self-service, agent assist technology, workflow automation, as well as workforce optimization solutions that optimize call center efficiency, and manage interaction quality and agent performance.
About SANA Sana Biotechnology Inc.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.